Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Release Date: September 30, 2025

Expiration Date: September 30, 2026

Activity Overview

This Community Practice Connection™ program provides an in-depth review of some highlights from the 2025 Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies. This unique and engaging multimedia activity is ideal for community-based clinicians and focuses on the practical aspects of using PSMA-targeted imaging and radioligand therapy to manage patients with prostate cancer, helping clinicians to place recent clinical trial data into context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Target Audience

This educational program is primarily directed toward community-based oncologists, radiation oncologists, nuclear medicine physicians, advanced practice providers, and other health care professionals involved in the treatment of prostate cancer.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Evaluate the diagnostic and prognostic significance of PSMA PET imaging in advanced prostate cancer and integrate imaging findings into systemic treatment decisions
• Assess recent clinical trial evidence supporting PSMA-targeted radioligand therapies and determine patient eligibility and optimal timing for initiation within community oncology practice
• Implement patient-centered strategies for managing PSMA-directed radioligand therapy, including effective sequencing with androgen receptor signaling inhibitors (ARSIs), chemotherapy, and novel combination therapies
• Identify practical barriers to accessing and delivering PSMA-directed imaging and radioligand therapy in community practice settings and develop collaborative solutions to expand equitable patient access